Aurora Cannabis Inc. (TSX:ACB)
4.670
-0.120 (-2.51%)
Apr 28, 2026, 4:00 PM EST
Aurora Cannabis Revenue
Aurora Cannabis had revenue of 94.19M CAD in the quarter ending December 31, 2025, with 6.79% growth. This brings the company's revenue in the last twelve months to 373.12M, up 16.54% year-over-year. In the fiscal year ending March 31, 2025, Aurora Cannabis had annual revenue of 343.29M with 27.32% growth.
Revenue (ttm)
373.12M
Revenue Growth
+16.54%
P/S Ratio
0.76
Revenue / Employee
347.73K
Employees
1,073
Market Cap
283.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 343.29M | 73.66M | 27.32% |
| Mar 31, 2024 | 269.64M | 45.83M | 20.48% |
| Mar 31, 2023 | 223.80M | 2.47M | 1.11% |
| Jun 30, 2022 | 221.34M | -23.91M | -9.75% |
| Jun 30, 2021 | 245.25M | -23.45M | -8.73% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Organigram Global | 279.99M |
| TerrAscend | 357.26M |
| Auxly Cannabis Group | 151.48M |
| Cannara Biotech | 113.01M |
| Cipher Pharmaceuticals | 69.17M |
| BioSyent | 43.05M |
| Ascend Wellness Holdings | 686.36M |
| HLS Therapeutics | 76.10M |
Aurora Cannabis News
- 14 hours ago - Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets - PRNewsWire
- 5 days ago - 'Big Business Opportunity': Cannabis CEO Celebrates DOJ Easing Regulations On Medical Marijuana - Forbes
- 5 days ago - The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off - Market Watch
- 5 days ago - Aurora Cannabis (ACB) Benefits from Rescheduling of Cannabis Products - GuruFocus
- 5 days ago - Aurora Cannabis (ACB) Sees Regulatory Shift Towards Medical Marijuana Research - GuruFocus
- 5 days ago - Cannabis rescheduling fuels optimism across industry - Reuters
- 6 days ago - Why are cannabis stocks surging today? - Invezz
- 6 days ago - Aurora Cannabis (ACB) Set to Benefit from Potential Reclassification of Cannabis - GuruFocus